N‐Terminal Modification of Gly‐His‐Tagged Proteins with Azidogluconolactone

Site‐specific protein modifications are vital for biopharmaceutical drug development. Gluconoylation is a non‐enzymatic, post‐translational modification of N‐terminal HisTags. We report high‐yield, site‐selective in vitro α‐aminoacylation of peptides, glycoproteins, antibodies, and virus‐like partic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chembiochem : a European journal of chemical biology Jg. 22; H. 22; S. 3199 - 3207
Hauptverfasser:	Brune, Karl D., Liekniņa, Ilva, Sutov, Grigorij, Morris, Alexander R., Jovicevic, Dejana, Kalniņš, Gints, Kazāks, Andris, Kluga, Rihards, Kastaljana, Sabine, Zajakina, Anna, Jansons, Juris, Skrastiņa, Dace, Spunde, Karīna, Cohen, Alexander A., Bjorkman, Pamela J., Morris, Howard R., Suna, Edgars, Tārs, Kaspars
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Weinheim Wiley Subscription Services, Inc 16.11.2021
Schlagworte:	Aminoacylation Antibodies Antigens Biopharmaceuticals click chemistry COVID-19 COVID-19 vaccines Drug development Esters Glycoproteins Glycosylation immunology nanoparticles Peptides protein modifications Proteins R&D Research & development Seroconversion Severe acute respiratory syndrome coronavirus 2 site-specific conjugation Viruses Yeast
ISSN:	1439-4227, 1439-7633, 1439-7633
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!